HLS Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call

TORONTO, March 14, 2022 /CNW/ – HLS Therapeutics Inc. (“HLS” or the “Company”) HLSannounces that it will release its fourth quarter and full year 2021 financial results on Thursday, March 17, 2022. The Company will hold a conference call the same day at 8:30 a.m. ET to discuss their results. The call will be moderated by Mr. Gilbert Godingeneral manager and Mr. Tim HendricksonFinancial director. Slides accompanying the remarks prepared by management will be available for viewing via the webcast.

The recorded replay will be available for 14 days and the archived webcast will be available for 365 days.

[WATCH NOW] Former hedge fund trader Chris Capre teaches you how to trade options like a pro, even in the most volatile markets. Click here to watch on YouTube!

A link to the live audio webcast of the conference call will also be available on the events page of the investors section of the HLS Therapeutics website at www.hlstherapeutics.com. Please tune in at least 15 minutes before the conference call to ensure enough time for any software downloads that may be required to listen to the webcast.

Founded in 2015, HLS is a pharmaceutical company focused on acquiring and commercializing late-stage, commercial-stage branded pharmaceutical products established in North American markets. HLS focuses on products targeting the central nervous system and cardiovascular therapeutic areas. The HLS leadership team is comprised of seasoned pharmaceutical executives with strong track records of success in these therapeutic areas and managing products at each of these lifecycle stages. For more information visit: www.hlstherapeutics.com

SOURCE HLS Therapeutics Inc.

Quote View original content: http://www.newswire.ca/en/releases/archive/March2022/14/c1586.html

Michael P. Boser